Latest Issue of Science News


News

Novel approach fights leprosy

From San Francisco, at the Interscience Conference on Antimicrobial Agents and Chemotherapy

An antibiotic typically used to fight sinus infections and pneumonia shows remarkable potency against leprosy.

In a study of leprosy patients in the Philippines, Robert H. Gelber, a physician at the University of California, San Francisco and his team treated 10 men with oral moxifloxacin daily for 2 months, followed by standard drugs for leprosy. Within 2 weeks of the moxifloxacin therapy, skin lesions on the men were clearing up. Skin biopsies showed that in all 10 patients, Mycobacterium leprae—the microbe that causes the disease—was undetectable within a week or two.

"In my 40 years of treating leprosy, I've never seen anything like this," Gelber says.

Note: To comment, Science News subscribing members must now establish a separate login relationship with Disqus. Click the Disqus icon below, enter your e-mail and click “forgot password” to reset your password. You may also log into Disqus using Facebook, Twitter or Google.

X
This article is available only to subscribing members. Join SSP today or Log in.